Find uplifting stories about heroes, innovations, and solutions
8205 results for "treatment-resistant depression"
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
Thousands of people told their depression was "treatment-resistant" found relief when doctors treated their cardiovascular system instead of their brain. The discovery could transform care for the 30% of depression patients who don't respond to traditional medications.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
People with depression who haven't responded to medication found new hope through a strict low-carb diet in a groundbreaking Oxford study. The ketogenic approach delivered measurable improvements after just six weeks.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
Serenity Mental Health Centers just brought innovative ketamine therapy to Nocatee, Florida, offering new hope for patients struggling with depression and anxiety. The treatment is part of a personalized care approach that's breaking down barriers to mental health support.
A major clinical trial shows magnetic seizure therapy treats severe depression as effectively as electroconvulsive therapy, but with far fewer memory problems. This breakthrough could help thousands who avoid current treatments due to cognitive side effects.
New research shows one ketamine infusion can reduce severe depression symptoms within hours, not weeks. For people with treatment-resistant depression, this rapid-acting treatment offers hope when traditional antidepressants fail.
A quick, personalized brain stimulation therapy is now available in Arkansas for people whose depression hasn't responded to medication or counseling. The FDA-approved SAINT system at UAMS takes just five days and helps restore normal brain function.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Scientists discovered a simple blood marker that predicts which depression patients will respond to the most common antidepressants, potentially sparing millions from months of trying different medications. This breakthrough could transform how doctors treat the 330 million people worldwide living with major depression.
Scientists found that brain cells in young people with depression work overtime when resting but can't keep up under stress. This breakthrough could lead to earlier diagnosis and better treatments for millions struggling with the condition.
Researchers discovered a way to make treatment-resistant cancer cells vulnerable again by breaking down their DNA repair machinery. The breakthrough could help millions of patients whose cancers stopped responding to existing therapies.
A baseball cap that activates a tiny brain implant just won FDA approval for its first human trial. For people with treatment-resistant depression, this could transform morning routines into moments of healing.
A physicist-turned-biomedical engineer has developed a groundbreaking treatment using light to disable bacteria's defenses, making deadly antibiotic-resistant infections treatable again. The therapy has already saved lives in Brazil and could protect millions from infections that currently kill 4 million people annually.
Showing 20 of 8205